Selenic acid Withdrawn Phase 3 Trials for Thyroid Associated Ophthalmopathy Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02112643Selenium in Mild Thyroid Eye Disease in North America